Skip to main content
Log in

Megaesophagus microbiota: A qualitative and quantitative analysis

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Bacterial overgrowth in the esophageal lumen in patients with megaesophagus can be the cause of recurring pulmonary infections, infectious complications due to surgical or endoscopic procedures, and the development of dysplasia of the esophageal mucosa and cancer. Despite this, esophageal microbiota in the megaesophagus have never been studied. The aim of this study was to analyze qualitatively and quantitatively the microbiota in chagasic megaesophagus in comparison to the normal esophagus. Twenty-five patients (10 men and 15 women), ranging in age from 24 to 74 years (mean years), were prospectively studied from March to September 2000. Fifteen patients with chagasic megaesophagus were divided into three subgroups (n = 5 patients in each) according to the grade of esophageal dilation: MG1 = megaesophagus grade I; MG2 = megaesophagus grade II; and MG3 = megaesophagus grade III. Another group of 10 patients without esophageal disease served as a control group. Samples were collected using a method especially developed to avoid contamination with microorganisms ofthe oral cavity and oropharynx. In the control group, 40% of the cultures were positive with the genus Streptococcus predominating and concentrations varying from 101 to 102 colony-forming units/ml. In the megaesophagus group, 93.3% of the cultures were positive, with great variability in the bacteria and a predominance of various aerobic gram-positive bacteria (Streptococcus was most common) and anaerobic bacteria (Veillonella was most frequent) in concentrations that ranged from 101 to 105 colony-forming units/ml. The bacterial concentrations were generally more elevated in MG3 patients in comparison to MG1 and MG2 patients and the control group (P < 0.05). It was concluded that patients with megaesophagus have a variety of microbiota consisting mostly of aerobic gram-positive and anaerobic bacteria, in concentrations that varied according to the degree of esophageal dilation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duranceau AC, Deschamps E, Lafontaine E. What is the incidence of pulmonary complications in patients with achalasia? In Giuli R, McCallum RW, Skinner DB, eds. Primary Motility Disorders of the Esophagus. Paris: John Libbey Eurotext, 1986, 309–310.

    Google Scholar 

  2. Marshall JC. Gastrointestinal flora and its alterations in critical illness. Curr Opin Clin Nutr Metab Care 1999;2:405–411.

    Article  PubMed  CAS  Google Scholar 

  3. Queiroz DMM, Mendes EN. Microbiota do trato gastrointestinal. Gastroenterol Clín 1993;778-782.

  4. Koberle F. Patogenia da molestia de chagas. Rev Goiana Med 1957;3:155–1870.

    Google Scholar 

  5. Pinotti HW, Cecconello I, Zilberstein B. Megaesôfago. In: Pinotti HW, ed. Tratado de Clínica Cirúrgica do Aparelho Digestivo. São Paulo:1994;316–345.

  6. Rezende JM, Lauar KM, Oliveira AR. Aspectos clínicos e radiológicos da aperistalse do esôfago. Rev Bras Gastroenterol 1960;12:247–262.

    PubMed  Google Scholar 

  7. Rezende JM. Manifestações digestivas da doença de Chagas. Gastroenterologia Clín 1993;2:1729–1755.

    Google Scholar 

  8. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med 1995;237:419–427.

    Article  PubMed  CAS  Google Scholar 

  9. Lau WF, Wong J, Lam KH, Ong GB. Oesophageal microbial flora in carcinoma of the oesophagus. Aust N Z J Surg 1981;51:52–55.

    PubMed  CAS  Google Scholar 

  10. Finlay IG, Wright PA, Menzies T, McArdle CS. Microbial flora in carcinoma of oesophagus. Thorax 1982;37:181–184.

    PubMed  CAS  Google Scholar 

  11. Camara EL, Lima JA, Oliveira GB, Machado AS, Pulmonary findings in patients with chagasic megaesophagus. Study of autopsied cases. Chest 1983;83:87–91.

    PubMed  CAS  Google Scholar 

  12. Christie DL. Pulmonary complications of esophageal disease. Pediatr Clin North Am 1984;31:835–847.

    PubMed  CAS  Google Scholar 

  13. Iverson LI, May IA, Samson PC. Pulmonary complications in benign esophageal disease. Am J Surg 1973;126:223–228.

    Article  PubMed  CAS  Google Scholar 

  14. Borotto E, Gaudric M, Danel B, Samana J, Quartier S, Chaussad S, Couturire D. Risk factors of oesophageal perforation during pneumatic perforation for achalasia. Gut 1996;39:9–12.

    Article  PubMed  CAS  Google Scholar 

  15. Pinotti HW, Felix VN, Zilberstein B, Cecconello I. Surgical complications of chagas’ disease: Megaesophagus, achalasia of the pylorus and cholelithiasis. World J Surg 1991;15:198–204.

    Article  PubMed  CAS  Google Scholar 

  16. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia: A morphologic study of 42 resected specimens. Am J SurgPathol 1994;18:327–337.

    CAS  Google Scholar 

  17. Loviscek LF, Cenoz MC, Badaloni AE, Agarinakazato O. Early cancer in achalasia. Dis Esoph 1998;11:239–247.

    CAS  Google Scholar 

  18. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Muta Res 1994;305:253–264.

    CAS  Google Scholar 

  19. Zucoloto S, Rezende JM. Mucosal alterations in human chronic chagasic esophagopathy. Digestion 1990;47:138–142.

    Article  PubMed  CAS  Google Scholar 

  20. Yamamuro EM. Megaesôfago—mapeamento histológico da mucosa esofágia. São Paulo, 1998. Doctorial thesis.

  21. Ferreira-Santos R. Aperistalsis of the esophagus and the colon (megaesophagus and megacolon) etiologically related to Chagas’ disease. Am J Dig Dis 1961;6:700–726.

    Article  PubMed  CAS  Google Scholar 

  22. Machado WM, Moraes-Filho JP, Santos MAA, Betarello A. Jejunal flora of patients with megaesophagus secondary to Chagas disease. Trans R Soc Trop Med Hygiene 1989;83:199–201.

    Article  CAS  Google Scholar 

  23. Quintanilha AM, Santos MAA, Saad WA, Pinotti HW, Zilberstein B. Chagasic megacolon and proximal jejunal microbiota. Scand J Gastroenterol 2000;35:632–636.

    Article  Google Scholar 

  24. Nair LA, Reynolds JC, Parkman HP, Ouyang A, Strom BL, Rosato EF, Cohen S. Complications during pneumatic dilatation for achalasia or diffuse esophageal spasm: Analysis of risk factors, early clinical characteristics and outcome. Dig Dis Sci 1993;38:1893–1904.

    Article  PubMed  CAS  Google Scholar 

  25. Vaezi M, Richter JE. Current therapies for achalasia: Comparison and efficacy. J Clin Gastroenterol 1998;27:21–35.

    Article  PubMed  CAS  Google Scholar 

  26. Marchesini JB, Wiederkehr JC, Zeni Neto C, Repka JC, Brenner S, Malafaia OU, Coelho JC. Intragastric microflora study in patients with gastroduodenal disease. Arq Bras Cir Dig 1990;5:63–66.

    Google Scholar 

  27. Gagliardi D, Makihara S, Corsi PR, De Toledo Viana A, Wiczer MVFS, Nakakubo S, Mimiça LMJ. Microbial flora of the normal esophagus. Dis Esoph 1998;11:248–250.

    CAS  Google Scholar 

  28. Howard RS, Woodring JH, Vandiviere HM, Dillon ML. Mycobacterium fortuitum pulmonary infection complicating achalasia. South Med J 1991;84:1391–1393.

    PubMed  Google Scholar 

  29. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969;281:1137–1140.

    Article  PubMed  CAS  Google Scholar 

  30. de Oliveira RB, Troncon LEA, Dantas RO, Meneghelli UG. Gastrointestinal manifestations of Chagas’ disease. Am J Gastroenterol 1998;93:884–889.

    PubMed  Google Scholar 

  31. Hankins JR, McLaughlin JS. The association of carcinoma of esophagus with achalasia. J Thorac Cardiovasc Surg 1975;69:355–360.

    PubMed  CAS  Google Scholar 

  32. Peracchia A, Segalin A, Bardini R, Ruol A, Bonavina L, Baessato M. Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment. Hepatogastroenterology 1991;38:514–516.

    PubMed  CAS  Google Scholar 

  33. Hill MJ. Bacterial metabolism and human carcinogenesis. Br Med Bull 1980, 36:89–94.

    PubMed  CAS  Google Scholar 

  34. Calmels S, Ohshima H, Bartsch H. Nitrosamine formation by denitrifying and non-denitrifying bacteria: Implication of nitrite reductase and nitrate reductase in nitrosation catalysis. J Gen Microbiol 1988;134:221–226.

    PubMed  CAS  Google Scholar 

  35. Calmels S, Ohshima H, Henry Y, Bartsch H. Characterization of bacterial cytochrome cd 1-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines. Carcinogenesis 1996;17:533–536.

    Article  PubMed  CAS  Google Scholar 

  36. Calmels S, Bereziat JC, Bartsch H. Bacterial formation of N-nitroso compounds from administered precursos in the rat stomach after omeprazole-induced achlorhydria. Carcinogenesis 1991;12:435–439.

    Article  PubMed  CAS  Google Scholar 

  37. Reuber MD. Carcinomas of the esophagus in rats by diethylnitrosamine. Eur J Cancer 1975;11:97–99.

    PubMed  CAS  Google Scholar 

  38. Rubio CA, Liu F, Chejfec G, Sveander M. The induction of esophageal tumors in mice: Dose and time dependency. In Vivo 1987;1:35–38.

    PubMed  CAS  Google Scholar 

  39. Correa P. Is gastric carcinoma an infectious disease? N Engl J Med 1991;325:1170–1171.

    Article  PubMed  CAS  Google Scholar 

  40. Stockbrugger R, Cotton PB, Hill MJ, Walters CL. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 1982;23:1048–1054.

    Article  PubMed  CAS  Google Scholar 

  41. Verdu E, Viani F, Amstrong D, Fraser R, Siergrist HH, Pignatelli B, Fried M. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 1994;35:455–460.

    Article  PubMed  CAS  Google Scholar 

  42. Guadagni S, Walters CL, Smith PLR, Verzano R, Valenti M, Reed P. N-nitroso compounds in the gastric juice of normal controls, patients with partial gastrectomies and gastric cancer patients. J Surg Oncol 1996;53:226–233.

    Article  Google Scholar 

  43. Fein M, Fuchs KH, DeMeester TM, Peters JH, Witmann D, Weig M. Evaluation of the intestinal microflora in the rat model for esophageal adenocarcinoma. Dis Esoph 2000; 13:39–43.

    Article  CAS  Google Scholar 

  44. Weisburger JH, Raineri R. Assessment of human exposure and response to n-nitroso compounds: A new view on the etiology of digestive tract cancers. Toxicol Appl Pharmacol 1975;31:369–374.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by FAPESP (Fundação de Amparo á Pesquisa do Estado de São Paulo).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pajecki, D., Zilberstein, B., Santos, M.A.A.d. et al. Megaesophagus microbiota: A qualitative and quantitative analysis. J Gastrointest Surg 6, 723–729 (2002). https://doi.org/10.1016/S1091-255X(02)00028-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(02)00028-8

Key words

Navigation